ID   ENPP4_HUMAN             Reviewed;         453 AA.
AC   Q9Y6X5; A8K5G1; Q7L2N1;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 3.
DT   18-JUN-2025, entry version 161.
DE   RecName: Full=Bis(5'-adenosyl)-triphosphatase ENPP4;
DE            EC=3.6.1.29;
DE   AltName: Full=AP3A hydrolase;
DE            Short=AP3Aase;
DE   AltName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 4;
DE            Short=E-NPP 4;
DE            Short=NPP-4;
DE   Flags: Precursor;
GN   Name=ENPP4; Synonyms=KIAA0879, NPP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-144.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=11027689; DOI=10.1074/jbc.m007552200;
RA   Gijsbers R., Ceulemans H., Stalmans W., Bollen M.;
RT   "Structural and catalytic similarities between nucleotide
RT   pyrophosphatases/phosphodiesterases and alkaline phosphatases.";
RL   J. Biol. Chem. 276:1361-1368(2001).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22995898; DOI=10.1182/blood-2012-04-425215;
RA   Albright R.A., Chang W.C., Robert D., Ornstein D.L., Cao W., Liu L.,
RA   Redick M.E., Young J.I., De La Cruz E.M., Braddock D.T.;
RT   "NPP4 is a procoagulant enzyme on the surface of vascular endothelium.";
RL   Blood 120:4432-4440(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 16-407 IN COMPLEXES WITH ZINC AND
RP   AMP, FUNCTION, CATALYTIC ACTIVITY, DISULFIDE BOND, GLYCOSYLATION AT
RP   ASN-155; ASN-166 AND ASN-386, ACTIVE SITE, AND COFACTOR.
RX   PubMed=24338010; DOI=10.1074/jbc.m113.505867;
RA   Albright R.A., Ornstein D.L., Cao W., Chang W.C., Robert D., Tehan M.,
RA   Hoyer D., Liu L., Stabach P., Yang G., De La Cruz E.M., Braddock D.T.;
RT   "The molecular basis of purinergic signal metabolism by ecto-nucleotide
RT   pyrophosphatase/phosphodiesterases 4 and 1 and implications in stroke.";
RL   J. Biol. Chem. 289:3294-3306(2014).
CC   -!- FUNCTION: Hydrolyzes extracellular Ap3A into AMP and ADP, and Ap4A into
CC       AMP and ATP. Ap3A and Ap4A are diadenosine polyphosphates thought to
CC       induce proliferation of vascular smooth muscle cells. Acts as a
CC       procoagulant, mediating platelet aggregation at the site of nascent
CC       thrombus via release of ADP from Ap3A and activation of ADP receptors.
CC       {ECO:0000269|PubMed:22995898, ECO:0000269|PubMed:24338010}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=P(1),P(3)-bis(5'-adenosyl) triphosphate + H2O = AMP + ADP + 2
CC         H(+); Xref=Rhea:RHEA:13893, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:58529, ChEBI:CHEBI:456215, ChEBI:CHEBI:456216;
CC         EC=3.6.1.29; Evidence={ECO:0000269|PubMed:22995898,
CC         ECO:0000269|PubMed:24338010};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:24338010};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|PubMed:24338010};
CC   -!- INTERACTION:
CC       Q9Y6X5; P55061: TMBIM6; NbExp=3; IntAct=EBI-17442870, EBI-1045825;
CC       Q9Y6X5; Q9BVK8: TMEM147; NbExp=3; IntAct=EBI-17442870, EBI-348587;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22995898};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:22995898}.
CC   -!- TISSUE SPECIFICITY: Expressed on the surface of vascular endothelia.
CC       {ECO:0000269|PubMed:22995898}.
CC   -!- SIMILARITY: Belongs to the nucleotide pyrophosphatase/phosphodiesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020686; BAA74902.2; -; mRNA.
DR   EMBL; AK291276; BAF83965.1; -; mRNA.
DR   EMBL; AL035701; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC018054; AAH18054.1; -; mRNA.
DR   CCDS; CCDS34468.1; -.
DR   PIR; A59389; A59389.
DR   RefSeq; NP_055751.1; NM_014936.5.
DR   PDB; 4LQY; X-ray; 1.54 A; A=16-407.
DR   PDB; 4LR2; X-ray; 1.50 A; A=16-407.
DR   PDBsum; 4LQY; -.
DR   PDBsum; 4LR2; -.
DR   AlphaFoldDB; Q9Y6X5; -.
DR   SMR; Q9Y6X5; -.
DR   BioGRID; 116542; 28.
DR   FunCoup; Q9Y6X5; 672.
DR   IntAct; Q9Y6X5; 23.
DR   STRING; 9606.ENSP00000318066; -.
DR   GlyCosmos; Q9Y6X5; 4 sites, No reported glycans.
DR   GlyGen; Q9Y6X5; 9 sites, 21 N-linked glycans (8 sites).
DR   iPTMnet; Q9Y6X5; -.
DR   PhosphoSitePlus; Q9Y6X5; -.
DR   SwissPalm; Q9Y6X5; -.
DR   BioMuta; ENPP4; -.
DR   DMDM; 172045555; -.
DR   jPOST; Q9Y6X5; -.
DR   MassIVE; Q9Y6X5; -.
DR   PaxDb; 9606-ENSP00000318066; -.
DR   PeptideAtlas; Q9Y6X5; -.
DR   ProteomicsDB; 86816; -.
DR   Pumba; Q9Y6X5; -.
DR   Antibodypedia; 2757; 117 antibodies from 21 providers.
DR   DNASU; 22875; -.
DR   Ensembl; ENST00000321037.5; ENSP00000318066.3; ENSG00000001561.7.
DR   GeneID; 22875; -.
DR   KEGG; hsa:22875; -.
DR   MANE-Select; ENST00000321037.5; ENSP00000318066.3; NM_014936.5; NP_055751.1.
DR   UCSC; uc003oxy.4; human.
DR   AGR; HGNC:3359; -.
DR   CTD; 22875; -.
DR   DisGeNET; 22875; -.
DR   GeneCards; ENPP4; -.
DR   HGNC; HGNC:3359; ENPP4.
DR   HPA; ENSG00000001561; Low tissue specificity.
DR   MIM; 617000; gene.
DR   neXtProt; NX_Q9Y6X5; -.
DR   OpenTargets; ENSG00000001561; -.
DR   PharmGKB; PA27794; -.
DR   VEuPathDB; HostDB:ENSG00000001561; -.
DR   eggNOG; KOG2645; Eukaryota.
DR   GeneTree; ENSGT00940000158831; -.
DR   HOGENOM; CLU_017594_1_2_1; -.
DR   InParanoid; Q9Y6X5; -.
DR   OMA; DVCIDHS; -.
DR   OrthoDB; 415411at2759; -.
DR   PAN-GO; Q9Y6X5; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9Y6X5; -.
DR   TreeFam; TF330032; -.
DR   BRENDA; 3.6.1.17; 2681.
DR   PathwayCommons; Q9Y6X5; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q9Y6X5; -.
DR   BioGRID-ORCS; 22875; 7 hits in 1148 CRISPR screens.
DR   EvolutionaryTrace; Q9Y6X5; -.
DR   GenomeRNAi; 22875; -.
DR   Pharos; Q9Y6X5; Tbio.
DR   PRO; PR:Q9Y6X5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9Y6X5; protein.
DR   Bgee; ENSG00000001561; Expressed in bronchial epithelial cell and 199 other cell types or tissues.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; IDA:UniProtKB.
DR   GO; GO:0046130; P:purine ribonucleoside catabolic process; IDA:UniProtKB.
DR   CDD; cd16018; Enpp; 1.
DR   FunFam; 3.40.720.10:FF:000035; Ectonucleotide pyrophosphatase/phosphodiesterase 4 (Putative); 1.
DR   FunFam; 3.30.1360.180:FF:000004; Ectonucleotide pyrophosphatase/phosphodiesterase family member 4; 1.
DR   Gene3D; 3.30.1360.180; -; 1.
DR   Gene3D; 3.40.720.10; Alkaline Phosphatase, subunit A; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   PANTHER; PTHR10151:SF79; BIS(5'-ADENOSYL)-TRIPHOSPHATASE ENPP4; 1.
DR   PANTHER; PTHR10151; ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   SUPFAM; SSF53649; Alkaline phosphatase-like; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Blood coagulation; Cell membrane; Disulfide bond;
KW   Glycoprotein; Hemostasis; Hydrolase; Membrane; Metal-binding;
KW   Proteomics identification; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Zinc.
FT   SIGNAL          1..15
FT                   /evidence="ECO:0000255"
FT   CHAIN           16..453
FT                   /note="Bis(5'-adenosyl)-triphosphatase ENPP4"
FT                   /id="PRO_0000324795"
FT   TOPO_DOM        16..407
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        408..428
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        429..453
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        70
FT                   /note="AMP-threonine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         34
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT   BINDING         70
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT   BINDING         91
FT                   /ligand="substrate"
FT   BINDING         154
FT                   /ligand="substrate"
FT   BINDING         189
FT                   /ligand="substrate"
FT   BINDING         189
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT   BINDING         193
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT   BINDING         237
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT   BINDING         238
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT   BINDING         336
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT   CARBOHYD        155
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24338010"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24338010"
FT   CARBOHYD        276
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        386
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24338010"
FT   DISULFID        254..287
FT                   /evidence="ECO:0000269|PubMed:24338010"
FT   DISULFID        394..401
FT                   /evidence="ECO:0000269|PubMed:24338010"
FT   VARIANT         144
FT                   /note="H -> Q (in dbSNP:rs7451713)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_039884"
FT   VARIANT         255
FT                   /note="I -> V (in dbSNP:rs9381429)"
FT                   /id="VAR_039885"
FT   VARIANT         439
FT                   /note="S -> A (in dbSNP:rs16874289)"
FT                   /id="VAR_039886"
FT   CONFLICT        39
FT                   /note="D -> G (in Ref. 3; BAF83965)"
FT                   /evidence="ECO:0000305"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           40..43
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           47..54
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          56..63
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           70..79
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           83..86
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          90..94
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   TURN            96..98
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           110..112
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   TURN            113..115
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           119..124
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          130..135
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   TURN            137..140
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           160..172
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          178..185
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           189..195
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           200..223
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   TURN            227..229
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          231..235
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           251..253
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           257..259
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          260..264
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          266..275
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           277..284
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          291..295
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          313..318
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           343..345
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          349..353
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   STRAND          358..366
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           367..369
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           370..378
FT                   /evidence="ECO:0007829|PDB:4LR2"
FT   HELIX           389..395
FT                   /evidence="ECO:0007829|PDB:4LR2"
SQ   SEQUENCE   453 AA;  51641 MW;  BC82FA36D9B587C4 CRC64;
     MKLLVILLFS GLITGFRSDS SSSLPPKLLL VSFDGFRADY LKNYEFPHLQ NFIKEGVLVE
     HVKNVFITKT FPNHYSIVTG LYEESHGIVA NSMYDAVTKK HFSDSNDKDP FWWNEAVPIW
     VTNQLQENRS SAAAMWPGTD VPIHDTISSY FMNYNSSVSF EERLNNITMW LNNSNPPVTF
     ATLYWEEPDA SGHKYGPEDK ENMSRVLKKI DDLIGDLVQR LKMLGLWENL NVIITSDHGM
     TQCSQDRLIN LDSCIDHSYY TLIDLSPVAA ILPKINRTEV YNKLKNCSPH MNVYLKEDIP
     NRFYYQHNDR IQPIILVADE GWTIVLNESS QKLGDHGYDN SLPSMHPFLA AHGPAFHKGY
     KHSTINIVDI YPMMCHILGL KPHPNNGTFG HTKCLLVDQW CINLPEAIAI VIGSLLVLTM
     LTCLIIIMQN RLSVPRPFSR LQLQEDDDDP LIG
//
